Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hussain: Empowering Workers is the Key to Data Integrity

This article was originally published in The Gold Sheet

Executive Summary

Why would pharmaceutical quality personnel fib about something like a batch test? Ajaz Hussain, the former FDA’er who helped launch the 21st Century Quality Paradigm, may have found the answer in the science of human behavioral economics.

You may also be interested in...



Confronting Illusions of Quality in Indian Generics Manufacturing

A sharp increase in data integrity findings has raised questions about the quality of pharmaceutical manufacturing in India. What’s happening and why, who’s responsible, and how can drug makers and the regulatory agencies that watch over them put a stop to it?

Thakur: Data Integrity Requires Stronger Local Enforcement

There is a better answer to India’s data integrity crisis than putting 19 American inspectors there to enforce U.S. standards in country of a billion people. India’s own inspectorate needs to step up its game, says Dinesh Thakur, who nine years ago first alerted FDA to the problems at one firm, Ranbaxy.

Cahilly: Focus on India Masks the Real Data Integrity Problems

The problem of data integrity is not so much with a supplier or contract manufacturer halfway around the world, says Monica Cahilly. It’s more about that pdf you just printed from your electronic information system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel